In this webinar with StressMarq President & CEO Ariel Louwrier, fibrillar and oligomeric constructs of neurodegenerative disease associated peptides and their utility in disease modelling is examined.

StressMarq is the market leader in the development and commercialization of a range of unique fibrillar, oligomeric, and monomeric protein preparations for use in neurodegenerative disease research, including proteins such as alpha synuclein, tau, amyloid beta, SOD1 and TTR. StressMarq’s strategic efforts are focused on expanding the breadth and depth of this product offering to assist researchers studying Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative diseases.

StressMarq’s alpha synuclein, tau, and amyloid beta proteins for neurodegenerative disease research have been cited in many peer-reviewed scientific journals. Check out our website for a comprehensive list of citations for these proteins.

In addition to our focus on fibrillar proteins for neurodegenerative disease research, our diverse portfolio of antibodies, kits, small molecules, and other proteins are utilized across a range of life sciences including neuroscience, cancer research and cell signaling.

StressMarq products are available worldwide through an extensive network of international distributors in over 45 countries.

Watch the webinar to learn about the different varieties of protein constructs and their characteristics, as well as the effects of sonication on pre-formed fibrils (PFFs).

Have questions? Submit them here: